Evidence map›Paper›PMID 40714561›Full record

ArticleSTAR protocols2025

Protocol for developing a mouse model of post-primary pulmonary tuberculosis after hematogenous spread in native lungs and lung implants.

Shivraj M Yabaji, Suruchi Lata, Igor Gavrish, Ming Lo, Aoife K O'Connell, Hans P Gertje, Colleen E Thurman, Nicholas A Crossland, Lester Kobzik, Igor Kramnik

Abstract read
In one paragraph

Article in STAR protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shivraj M YabajiThe National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA 02118, USA.
Suruchi LataThe National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA 02118, USA.
Igor GavrishThe National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA 02118, USA.
Ming LoThe National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA 02118, USA.
Aoife K O'ConnellThe National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA 02118, USA.
Hans P GertjeThe National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA 02118, USA.
Colleen E ThurmanThe National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA 02118, USA.
Nicholas A CrosslandThe National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA 02118, USA; The Department of Pathology and Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA 02118, USA.
Lester KobzikCellecta, Inc., Mountain View, CA, USA.
Igor KramnikThe National Emerging Infectious Diseases Laboratories (NEIDL), Boston University, Boston, MA 02118, USA; Pulmonary Center, The Department of Medicine, Boston University Chobanian & Aveedisian School of Medicine, Boston, MA 02118, USA. Electronic address: ikramnik@bu.edu.

Funding

Necrosis in pulmonary TB granulomas: dynamics, mechanisms, therapiesR01HL126066 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KRAMNIK, IGOR, NIEDERWEIS, MICHAEL · 2016 to 2025
$5.6M
Vectra Polaris Quantitative Pathology Imaging SystemS10OD030269 · OD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CROSSLAND, NICHOLAS ALEXANDER · 2021 to 2021
$402k
Ventana Discovery Ultra Research Autostainer: an Ex+ Core serviceS10OD026983 · OD · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CROSSLAND, NICHOLAS ALEXANDER · 2019 to 2019
$207k
NHLBI NIH HHS R01 HL126066NIH HHS S10 OD026983NIH HHS S10 OD030269
6 · The paper itself

Abstract

Here, we present a protocol for a mouse model for studying mechanisms of post-primary pulmonary tuberculosis (PTB) caused by virulent Mycobacterium tuberculosis (Mtb) using subcutaneous hock infection and lung tissue implantation. We describe steps for collagen instillation of lungs, lung and spleen implantation, preparation of Mtb for infection, and hock infection of mice. We then detail procedures for the perfusion of the lung and collection of organs, tissue processing, and histopathologic interpretation. For complete details on the use and execution of this protocol, please refer to Yabaji et al.

Indexed as

Disease Models, AnimalLungMycobacterium tuberculosisTuberculosis, PulmonaryAnimalsMiceSpleenImmunologyMicrobiologyModel Organisms

Identifiers

PMID40714561
PMCPMC12311599

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.